Keywords: dupont, merck, revia, gains, approval, alcoholism, formerly

DuPont Merck's ReVia Gains US Approval For Alcoholism

Article | 16 January 1995

Print This

DuPont Merck's ReVia (formerly Trexan; naltrexone) has been approved for the treatment of alcoholism in the USA. It has already ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in